BIOMAT Database Logo BIOMAT Database Logo

Elastase released from human granulocytes stimulated with N-formyl-chemotactic peptide prevents activation of tumor cell prourokinase (pro-uPA). 1989

M Schmitt, and N Kanayama, and A Henschen, and A Hollrieder, and R Hafter, and D Gulba, and F Jänicke, and H Graeff
Frauenklinik der Technischen Universität München, FRG.

Proteolytic enzymes released from granulocytes upon stimulation with the chemotactic N-formyl peptide FNLPNTL (in the presence of cytochalasin B) prevented activation of tumor cell single-chain urokinase-type plasminogen activator (pro-uPA) by plasmin. Elastase was identified by the use of eglin C (elastase inhibitor) and a monoclonal antibody to elastase as the functional proteolytic enzyme in granulocyte supernatants. Action of purified granulocyte elastase on pro-uPA generated enzymatically inactive two-chain uPA linked by disulfide bridges which was indistinguishable by SDS-PAGE from plasmin-generated HMW-uPA. The major elastase cleavage site in pro-uPA was located between Ile159 and Ile160. a minor one between Thr165 and Thr166. Elastase cannot substitute for plasmin in the proteolytic activation of pro-uPA to enzymatically active HMW-uPA. However, when pro-uPA was first activated by plasmin to form enzymatically active HMW-uPA, this enzymatic activity was not impaired by subsequent elastase treatment.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010196 Pancreatic Elastase A protease of broad specificity, obtained from dried pancreas. Molecular weight is approximately 25,000. The enzyme breaks down elastin, the specific protein of elastic fibers, and digests other proteins such as fibrin, hemoglobin, and albumin. EC 3.4.21.36. Elastase,Pancreatopeptidase,Elastase I,Pancreatic Elastase I,Elastase I, Pancreatic,Elastase, Pancreatic
D010960 Plasminogen Activators A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Extrinsic Plasminogen Activators,Plasminogen Activator,Uterine-Tissue Plasminogen Activator,Uterine Tissue Plasminogen Activator
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002630 Chemotactic Factors Chemical substances that attract or repel cells. The concept denotes especially those factors released as a result of tissue injury, microbial invasion, or immunologic activity, that attract LEUKOCYTES; MACROPHAGES; or other cells to the site of infection or insult. Chemoattractant,Chemotactic Factor,Chemotaxin,Chemotaxins,Cytotaxinogens,Cytotaxins,Macrophage Chemotactic Factor,Chemoattractants,Chemotactic Factors, Macrophage,Macrophage Chemotactic Factors,Chemotactic Factor, Macrophage,Factor, Chemotactic,Factor, Macrophage Chemotactic
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D006098 Granulocytes Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS. Granulocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Schmitt, and N Kanayama, and A Henschen, and A Hollrieder, and R Hafter, and D Gulba, and F Jänicke, and H Graeff
The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
January 1982, Journal of cellular biochemistry,
M Schmitt, and N Kanayama, and A Henschen, and A Hollrieder, and R Hafter, and D Gulba, and F Jänicke, and H Graeff
Evidence for N-formyl chemotactic peptide-stimulated GTPase activity in human neutrophil homogenates.
January 1984, FEBS letters,
M Schmitt, and N Kanayama, and A Henschen, and A Hollrieder, and R Hafter, and D Gulba, and F Jänicke, and H Graeff
Chemotactic receptor of cord blood granulocytes to the synthesized chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
January 1983, Pediatric research,
M Schmitt, and N Kanayama, and A Henschen, and A Hollrieder, and R Hafter, and D Gulba, and F Jänicke, and H Graeff
The fate of an N-formylated chemotactic peptide in stimulated human granulocytes. Subcellular fractionation studies.
February 1983, The Journal of biological chemistry,
M Schmitt, and N Kanayama, and A Henschen, and A Hollrieder, and R Hafter, and D Gulba, and F Jänicke, and H Graeff
Oxidation of n-formyl methionyl chemotactic peptide by human neutrophils.
April 1981, Journal of immunology (Baltimore, Md. : 1950),
M Schmitt, and N Kanayama, and A Henschen, and A Hollrieder, and R Hafter, and D Gulba, and F Jänicke, and H Graeff
Human granulocytes and granulocytes from other species demonstrate differences in chemotactic responsiveness to oxidized N-formyl-methionyl-leucyl-phenylalanine.
January 1989, Comparative biochemistry and physiology. A, Comparative physiology,
M Schmitt, and N Kanayama, and A Henschen, and A Hollrieder, and R Hafter, and D Gulba, and F Jänicke, and H Graeff
Intracellular localization of N-formyl chemotactic receptor and Mg2+ dependent ATPase in human granulocytes.
December 1982, Biochimica et biophysica acta,
M Schmitt, and N Kanayama, and A Henschen, and A Hollrieder, and R Hafter, and D Gulba, and F Jänicke, and H Graeff
Activation of neutrophils by N-formyl chemotactic peptides.
September 1984, Federation proceedings,
M Schmitt, and N Kanayama, and A Henschen, and A Hollrieder, and R Hafter, and D Gulba, and F Jänicke, and H Graeff
Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
December 1990, Biochemical and biophysical research communications,
M Schmitt, and N Kanayama, and A Henschen, and A Hollrieder, and R Hafter, and D Gulba, and F Jänicke, and H Graeff
Swainsonine induced modification of N-linked oligosaccharides on human phagocytic cell formyl peptide chemotactic receptors.
January 1987, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Copied contents to your clipboard!